Literature DB >> 15633459

Involvement of cAMP in neuronal survival and axonal regeneration.

Qi Cui1, Kwok-Fai So.   

Abstract

In vitro, cAMP elevation alters neuronal responsiveness to diffusible growth factors and overcomes myelin-associated inhibitory molecules. Significant advances have been made recently in understanding the role of increases in cAMP in promoting axonal growth. Importantly, it has now been shown that cAMP elevation can promote axonal regeneration and functional recovery after central nervous system injury. Elevation of cAMP can be achieved via either direct application of cAMP analogs or an inhibitor of the enzyme phosphodiesterase that degrades cAMP in vivo. Current information points to a number of protein kinase A-mediated pathways (mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/akt pathway activation and Rho inactivation) underlying cAMP elevation-induced neuronal survival and axonal regeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15633459     DOI: 10.1111/j.1447-073x.2004.00089.x

Source DB:  PubMed          Journal:  Anat Sci Int        ISSN: 1447-073X            Impact factor:   1.741


  19 in total

1.  Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury.

Authors:  Joyce A Benjamins; Liljana Nedelkoska
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

2.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 3.  Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.

Authors:  Antonella Cardinale; Francesca R Fusco
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

4.  Pterostilbene attenuates amyloid-β induced neurotoxicity with regulating PDE4A-CREB-BDNF pathway.

Authors:  Jiao Meng; Yuhua Chen; Fangfang Bi; Hua Li; Cuicui Chang; Wei Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

6.  Dose and chemical modification considerations for continuous cyclic AMP analog delivery to the injured CNS.

Authors:  Karim Fouad; Mousumi Ghosh; Romana Vavrek; Arthur D Tse; Damien D Pearse
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

7.  Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Inderjit Singh; Robert B Skoff; Avtar K Singh
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

8.  Phosphodiesterase 4 and 7 inhibitors produce protective effects against high glucose-induced neurotoxicity in PC12 cells via modulation of the oxidative stress, apoptosis and inflammation pathways.

Authors:  Nazanin Namazi Sarvestani; Saeedeh Saberi Firouzi; Reza Falak; Mohammad Yahya Karimi; Mohammad Davoodzadeh Gholami; Akram Rangbar; Asieh Hosseini
Journal:  Metab Brain Dis       Date:  2018-04-30       Impact factor: 3.584

9.  Protein kinases and phosphatases in the control of cell fate.

Authors:  Angela Bononi; Chiara Agnoletto; Elena De Marchi; Saverio Marchi; Simone Patergnani; Massimo Bonora; Carlotta Giorgi; Sonia Missiroli; Federica Poletti; Alessandro Rimessi; Paolo Pinton
Journal:  Enzyme Res       Date:  2011-09-04

10.  O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.

Authors:  Herb Francisco; Katherine Kollins; Neal Varghis; David Vocadlo; Keith Vosseller; Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2009 Feb 1-15       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.